Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912093257> ?p ?o ?g. }
- W2912093257 endingPage "474" @default.
- W2912093257 startingPage "469" @default.
- W2912093257 abstract "Several evidence pointed out the role of epigenetics in Alzheimer’s disease (AD) revealing strictly relationships between epigenetic and “classical” AD targets. Based on the reported connection among histone deacetylases (HDACs) and glycogen synthase kinase 3β (GSK-3β), herein we present the discovery and the biochemical characterization of the first-in-class hit compound able to exert promising anti-AD effects by modulating the targeted proteins in the low micromolar range of concentration. Compound 11 induces an increase in histone acetylation and a reduction of tau phosphorylation. It is nontoxic and protective against H2O2 and 6-OHDA stimuli in SH-SY5Y and in CGN cell lines, respectively. Moreover, it promotes neurogenesis and displays immunomodulatory effects. Compound 11 shows no lethality in a wt-zebrafish model (<100 μM) and high water solubility." @default.
- W2912093257 created "2019-02-21" @default.
- W2912093257 creator A5003379013 @default.
- W2912093257 creator A5008442547 @default.
- W2912093257 creator A5009838899 @default.
- W2912093257 creator A5017369751 @default.
- W2912093257 creator A5018237812 @default.
- W2912093257 creator A5020949961 @default.
- W2912093257 creator A5023140151 @default.
- W2912093257 creator A5031650006 @default.
- W2912093257 creator A5033637579 @default.
- W2912093257 creator A5040940946 @default.
- W2912093257 creator A5042642459 @default.
- W2912093257 creator A5044733733 @default.
- W2912093257 creator A5044837831 @default.
- W2912093257 creator A5055231606 @default.
- W2912093257 creator A5067808979 @default.
- W2912093257 creator A5072879742 @default.
- W2912093257 creator A5072918615 @default.
- W2912093257 creator A5074424627 @default.
- W2912093257 creator A5078908851 @default.
- W2912093257 creator A5081443257 @default.
- W2912093257 creator A5082141553 @default.
- W2912093257 creator A5085277820 @default.
- W2912093257 creator A5090475908 @default.
- W2912093257 date "2019-02-04" @default.
- W2912093257 modified "2023-09-29" @default.
- W2912093257 title "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease" @default.
- W2912093257 cites W1577837690 @default.
- W2912093257 cites W1982101530 @default.
- W2912093257 cites W1982848861 @default.
- W2912093257 cites W1982958012 @default.
- W2912093257 cites W2020339549 @default.
- W2912093257 cites W2034753731 @default.
- W2912093257 cites W2044025814 @default.
- W2912093257 cites W2050568934 @default.
- W2912093257 cites W2054433610 @default.
- W2912093257 cites W2063078660 @default.
- W2912093257 cites W2068995330 @default.
- W2912093257 cites W2077733632 @default.
- W2912093257 cites W2087961967 @default.
- W2912093257 cites W2094383719 @default.
- W2912093257 cites W2095026025 @default.
- W2912093257 cites W2101611410 @default.
- W2912093257 cites W2107339320 @default.
- W2912093257 cites W2113072452 @default.
- W2912093257 cites W2146249493 @default.
- W2912093257 cites W2155836103 @default.
- W2912093257 cites W2157020351 @default.
- W2912093257 cites W2175377156 @default.
- W2912093257 cites W2333146195 @default.
- W2912093257 cites W2499955277 @default.
- W2912093257 cites W2515990322 @default.
- W2912093257 cites W2615166509 @default.
- W2912093257 cites W2618318632 @default.
- W2912093257 cites W2783897572 @default.
- W2912093257 cites W2787019366 @default.
- W2912093257 cites W2788957403 @default.
- W2912093257 doi "https://doi.org/10.1021/acsmedchemlett.8b00507" @default.
- W2912093257 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6746190" @default.
- W2912093257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31531210" @default.
- W2912093257 hasPublicationYear "2019" @default.
- W2912093257 type Work @default.
- W2912093257 sameAs 2912093257 @default.
- W2912093257 citedByCount "30" @default.
- W2912093257 countsByYear W29120932572019 @default.
- W2912093257 countsByYear W29120932572020 @default.
- W2912093257 countsByYear W29120932572021 @default.
- W2912093257 countsByYear W29120932572022 @default.
- W2912093257 countsByYear W29120932572023 @default.
- W2912093257 crossrefType "journal-article" @default.
- W2912093257 hasAuthorship W2912093257A5003379013 @default.
- W2912093257 hasAuthorship W2912093257A5008442547 @default.
- W2912093257 hasAuthorship W2912093257A5009838899 @default.
- W2912093257 hasAuthorship W2912093257A5017369751 @default.
- W2912093257 hasAuthorship W2912093257A5018237812 @default.
- W2912093257 hasAuthorship W2912093257A5020949961 @default.
- W2912093257 hasAuthorship W2912093257A5023140151 @default.
- W2912093257 hasAuthorship W2912093257A5031650006 @default.
- W2912093257 hasAuthorship W2912093257A5033637579 @default.
- W2912093257 hasAuthorship W2912093257A5040940946 @default.
- W2912093257 hasAuthorship W2912093257A5042642459 @default.
- W2912093257 hasAuthorship W2912093257A5044733733 @default.
- W2912093257 hasAuthorship W2912093257A5044837831 @default.
- W2912093257 hasAuthorship W2912093257A5055231606 @default.
- W2912093257 hasAuthorship W2912093257A5067808979 @default.
- W2912093257 hasAuthorship W2912093257A5072879742 @default.
- W2912093257 hasAuthorship W2912093257A5072918615 @default.
- W2912093257 hasAuthorship W2912093257A5074424627 @default.
- W2912093257 hasAuthorship W2912093257A5078908851 @default.
- W2912093257 hasAuthorship W2912093257A5081443257 @default.
- W2912093257 hasAuthorship W2912093257A5082141553 @default.
- W2912093257 hasAuthorship W2912093257A5085277820 @default.
- W2912093257 hasAuthorship W2912093257A5090475908 @default.
- W2912093257 hasBestOaLocation W29120932572 @default.
- W2912093257 hasConcept C104317684 @default.
- W2912093257 hasConcept C119157956 @default.
- W2912093257 hasConcept C11960822 @default.